The New Political Economy of Pharmaceuticals

Description:

"Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its rules on pharmaceutical patents. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs and assesses the wider political economy of drug production and consumption in the Global South"--

subjects: Pharmaceutical policy,  International cooperation,  Pharmaceutical industry,  Drugs,  Patents,  Patents (International law),  POLITICAL SCIENCE / International Relations / General,  POLITICAL SCIENCE / Public Policy / Social Policy,  POLITICAL SCIENCE / Political Freedom & Security / Human Rights,  POLITICAL SCIENCE / Government / International,  SOCIAL SCIENCE / Developing Countries,  Generic drugs,  Law, developing countries,  Economic aspects,  POLITICAL SCIENCE,  International Relations,  General,  Public Policy,  Social Policy,  Political Freedom & Security,  Human Rights,  Government,  International,  SOCIAL SCIENCE,  Developing Countries,  Drug Industry,  Economics,  Health Policy,  Intellectual Property,  Pharmaceutical Preparations,  Arzneimittel,  Arzneimittelmarkt,  BUSINESS & ECONOMICS,  Industries,  Development economics & emerging economies,  Development studies,  Entwicklungsländer,  Geistiges Eigentum,  Gesundheitspolitik,  Gesundheitsversorgung,  Gewerblicher Rechtsschutz,  Human rights, civil rights,  Immaterialgüterrechte,  Industry & industrial studies,  Manufacturing industries,  Patentrecht,  Pharmaceutical industries,  Pharmaindustrie,  Pharmakologie,  Pharmazeutische Industrie,  Political economy,  TRIPS,  Weltgesundheitsorganisation,  World Health Organization